Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
69
days
Targeting SUV4–20H2-mediated H4K20 methylation restrains growth and migration in pediatric high-grade astrocytomas
Authors
Angeliki-Ioanna Giannopoulou; Elisavet Kosma; Dimitrios S. Kanakoglou; Alexia Klonou; Panagiotis Sarantis; Maria A. Papanikolaou; Andreas Mitsios; Spyros Sgouros; Penelope Korkolopoulou; Athanasios G. Papavassiliou; Christina PiperiShow moreShow less
Affiliations
Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens, 11527, Greece; First Department of Pathology, Medical School, National and Kapodistrian University of Athens, Athens, 11527, Greece; Department of Pediatric Neurosurgery, IASO Children’s Hospital, National and Kapodistrian University of Athens, Athens, 15123, GreeceShow moreShow less
167
days
Use of receptor and nonreceptor tyrosine kinase inhibitors and Parkinson disease risk
Authors
Giovanni R. Malaty; Jordan A. Killion; Sai Anmisha Doddamreddy; Osvaldo J. Laurido-Soto; Brad A. RacetteShow moreShow less
Affiliations
Department of Neurology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA; Department of Neurology, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA; Center for Advancing Health Services, Policy & Economics Research, Washington University, St. Louis, Missouri, USA; School of Public Health, University of the Witwatersrand, Johannesburg, South AfricaShow moreShow less
71
days
SNCA-targeted transcriptional repression therapy alleviates pathological and behavioral perturbations in a Parkinson's disease mouse model
Authors
Bernadette O'Donovan; Joseph Rittiner; Suraj Upadhya; Dellila Hodgson; Boris Kantor; Ornit Chiba-FalekShow moreShow less
Affiliations
Division of Translational Brain Sciences, Department of Neurology, Duke University School of Medicine, Durham, NC 27710, USA; Center for Genomic and Computational Biology, Duke University School of Medicine, Durham, NC 27710, USA; Department of Neurobiology, Duke University School of Medicine, Durham, NC 27710, USA; Viral Vector Core, Duke University School of Medicine, Durham, NC 27710, USA; Center for Advanced Genomic Technologies, Duke University School of Medicine, Durham, NC 27710, USAShow moreShow less
116
days
Integrative machine learning and single-nucleus transcriptomics reveal MAPK-centered neuronal responses underlying the potential Alzheimer's disease risk of GenX
Authors
Zongtang Xu; Yao Yang; Kun Xiang; Linpei Zhuo; Zheyu Fang; Xiaoou Lin; Conghui Dai; Jiaming Liu; Jing Sun; Qiuling TongShow moreShow less
Affiliations
Department of Neurology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325027, Zhejiang, China; Department of Preventive Medicine, School of Public Health, Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China; Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang, ChinaShow moreShow less
42
days
Association between statin treatment and outcomes after acute intracerebral hemorrhage in the third intensive care bundle with blood pressure reduction in acute cerebral haemorrhage trial study
Authors
Xing Wang; Menglu Ouyang; Xiaoying Chen; Laurent Billot; Qiang Li; Alejandra Malavera; Paula Muñoz Venturelli; Asita de Silva; Nguyen Huy Thang; Kolawole W. Wahab; Jeyaraj D. Pandian; Mohammad Wasay; Octavio M. Pontes-Neto; Carlos Abanto; Antonio Arauz; Carlos Delfino; Xin Li; Yuanbin Li; Xuejun Xu; Yang Liu; Mingsen Zhang; Craig S. Anderson; Xin Hu; Chao You; Lili Song; Lu MaShow moreShow less
Affiliations
Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, China; The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, Australia; Clinical Research Center, Faculty of Medicine Clinica Alemana Universidad del Desarrollo, Santiago, Chile; Clinical Trials Unit, Faculty of Medicine, University of Kelaniya, Colombo, Sri Lanka; Stroke Unit, 115 Hospital, Ho Chi Minh city, Viet Nam; Department of Medicine, University of Ilorin & University of Ilorin Teaching Hospital, Ilorin, Nigeria; Neurology Department, Christian Medical College and Hospital, Ludhiana, India; Department of Medicine, The Aga Khan University, Karachi, Pakistan; Department of Neuroscience and Behavioral Sciences, Ribeirão Preto Medical School, University of São Paulo, Ribeirao Preto, Brazil; Cerebrovascular Disease Research Center, National Institute of Neurological Sciences, Lima, Peru; Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez, Mexico City, Mexico; Institute of Science and Technology for Brain-inspired Intelligence, Fudan University, Shanghai, China; The First People's Hospital of Shenyang, Shenyang, China; Chongzhou People's Hospital, Chongzhou, China; The Second People's Hospital of Chengdu, Chengdu, China; The Third People's Hospital of Mianyang, Mianyang, China; The Second People's Hospital of Neijiang, Neijiang, China; Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence (Fudan University), Ministry of Education, China; Department of Neurology, Royal Prince Alfred Hospital, Sydney, AustraliaShow moreShow less
134
days
NTI164, a novel medicinal cannabis extract, improves core symptoms of autism spectrum disorder: Results from a double-blind, randomised, controlled trial (The Harmony study)
Authors
Brooke A. Keating; Yelda Ogru; Esra Isikgel; Kanan Sharma; Dima El-Sukkari; Michael C. FaheyShow moreShow less
Affiliations
Fenix Innovation Group, Mount Waverley, Victoria, Australia; Monash Children's Clinical Trial Centre, Monash Children's Hospital, Monash Health, Clayton, Victoria, Australia; Department of Neurology, Monash Children's Hospital, Monash Health, Clayton, Victoria, AustraliaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days